Screener
Tarsus Pharmaceuticals, Inc. TARS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s total assets?
- Tarsus Pharmaceuticals, Inc. (TARS) reported total assets of $611.14M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s total assets increased by 23.5% year-over-year, from $494.99M to $611.14M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s total assets has grown at a 26.7% compound annual growth rate (CAGR), from $171.97M to $562.16M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude